Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Froehner

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Aktuelle Urologie|November 25, 2025
Andreas Wiedemann, Andreas Manseck, Joachim Stein, et al.
Oncotarget|June 23, 2018
Role of WNT5A receptors FZD5 and RYK in prostate cancer cellsStefanie Thiele, Ariane Zimmer, Andy Göbel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 17, 2014
WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivoStefanie Thiele, Andy Göbel, Tilman D Rachner, et al.
Journal of Cancer Research and Clinical Oncology|May 10, 2017
Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detectionKarsten Salomo, Doreen Huebner, Manja U Boehme, et al.
BJU International|September 19, 2017
Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naïve patientsAngelika Borkowetz, Boris Hadaschik, Ivan Platzek, et al.
European Urology Oncology|October 23, 2018
Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer PatientsStephen B Williams, Ashish M Kamat, Karim Chamie, et al.
European Urology|July 8, 2020
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate CancerMarkus Kreuz, Dominik J Otto, Susanne Fuessel, et al.
European Urology Focus|July 30, 2017
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks AnalysisMalte W Vetterlein, Thomas Seisen, Matthias May, et al.
World Journal of Urology|February 10, 2015
Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladderVladimir Novotny, Michael Froehner, Matthias May, et al.
BJU International|November 11, 2014
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-makingAtiqullah Aziz, Shahrokh F Shariat, Florian Roghmann, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Aktuelle Urologie|November 25, 2025
Andreas Wiedemann, Andreas Manseck, Joachim Stein, et al.
Oncotarget|June 23, 2018
Role of WNT5A receptors FZD5 and RYK in prostate cancer cellsStefanie Thiele, Ariane Zimmer, Andy Göbel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 17, 2014
WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivoStefanie Thiele, Andy Göbel, Tilman D Rachner, et al.
Journal of Cancer Research and Clinical Oncology|May 10, 2017
Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detectionKarsten Salomo, Doreen Huebner, Manja U Boehme, et al.
BJU International|September 19, 2017
Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy-naïve patientsAngelika Borkowetz, Boris Hadaschik, Ivan Platzek, et al.
European Urology Oncology|October 23, 2018
Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer PatientsStephen B Williams, Ashish M Kamat, Karim Chamie, et al.
European Urology|July 8, 2020
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate CancerMarkus Kreuz, Dominik J Otto, Susanne Fuessel, et al.
European Urology Focus|July 30, 2017
Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks AnalysisMalte W Vetterlein, Thomas Seisen, Matthias May, et al.
World Journal of Urology|February 10, 2015
Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladderVladimir Novotny, Michael Froehner, Matthias May, et al.
BJU International|November 11, 2014
Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-makingAtiqullah Aziz, Shahrokh F Shariat, Florian Roghmann, et al.
Pageof 20